Chen Wang
Publications by Year
Research Areas
Chronic Obstructive Pulmonary Disease (COPD) Research, Pulmonary Hypertension Research and Treatments, Respiratory Support and Mechanisms, Asthma and respiratory diseases, COVID-19 Clinical Research Studies
Most-Cited Works
- → A novel coronavirus outbreak of global health concern(2020)8,079 cited
- → A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19(2020)5,500 cited
- → RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study(2021)4,256 cited
- → Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial(2020)3,652 cited
- → Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study(2018)1,671 cited
- → Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension(2013)1,363 cited
- → 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study(2023)883 cited
- → COVID-19 control in China during mass population movements at New Year(2020)878 cited
- → The Lancet Commission on lessons for the future from the COVID-19 pandemic(2022)835 cited
- → Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050(2023)762 cited